ORTIN GLOBAL

Price chart

Previous close

₹14.11

Open

₹14.04

Day high

₹14.79

Day low

₹13.25

Listed on NSE since 30 March 2021.

Market value

₹11.47 Cr

EPS (trailing)

₹-1.12

Price to book

10.61

Dividend yield

0.00%

Debt to equity

0.81

Profit margin

0.0%

Beta

0.57

Volume today

576

Average volume

11,907

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: ORTIN GLOBAL’s results filed with NSE, standalone (the company alone). Net profit is the share of ORTIN GLOBAL’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: ORTIN GLOBAL’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; research and development services for new formulation brands; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediate and developing new APIs; operates as a merchant exporter of finished pharmaceutical formulations; and engages in real estate. The company also exports all types of medicines including ayurvedic, homeopathic, unani, biochemical, nature cure products. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Hyderabad

Employees

8

Company website · Profile: Yahoo Finance

No headlines name ORTIN GLOBAL in the last day or two.

• Annual General Meeting

  Action · ex-date 22 September 2023

• Annual General Meeting

  Action · ex-date 23 September 2022

Source: NSE. Latest first.